Skip to main content

Georges Gemayel, Ph.D.

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Georges Gemayel, Ph.D.

Georges Gemayel, Ph.D. is recorded as Chairman and Board Member at Disc Medicine, Inc. (IRON). Disc Medicine, Inc. reported in an 8-K filed December 29, 2022 that Georges Gemayel, Ph.D. resigned as Interim President and Chief Executive Officer, effective December 29, 2022. Disc Medicine, Inc. reported in an 8-K filed December 29, 2022 that Georges Gemayel, Ph.D. was appointed Class II director, effective December 29, 2022.

“On December 29, 2022, immediately prior to and effective upon the closing of the Merger, Georges Gemayel, Ph.D., the Company's Interim President and Chief Executive Officer, ceased to be an officer of the Company, but is remaining a director of the Company.”
Disc Medicine, Inc. Form 8-K, filed December 29, 2022 · Read the filing
“Georges Gemayel, Mark Chin and Liam Ratcliff appointed as Class II directors, whose terms expire at the Company's 2024 annual meeting”
Disc Medicine, Inc. Form 8-K, filed December 29, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Disc Medicine, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.